Valuation (26%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.51 | N/A |
PEG Ratio (TTM) | 0.80 | N/A |
P/S Ratio (TTM) | 343.80 | N/A |
P/B Ratio (TTM) | 2.92 | N/A |
P/FCF Ratio (TTM) | -3.37 | N/A |
Price to 5YR AVG Earnings Ratio | -3.25 | N/A |
Price to 5YR AVG FCF Ratio | -6.47 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -97.24% | N/A |
ROE (TTM) | -103.92% | N/A |
Net Profit Margin (TTM) | -12,967.58% | N/A |
ROIC 5YR AVG | -60.34% | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -4.08% | -27.03% | -21.03% |
Revenue | -25.00% | -40.44% | -24.26% |
Net Income | -13.47% | -48.89% | -45.02% |
Cash Flow | -39.67% | -49.84% | -32.88% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 6.87 | N/A |
Quick Ratio (TTM) | 6.87 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | 2.25 | N/A |
LTL to 5YR AVG FCF | -0.09 | N/A |
Shares Outstanding Growth 5YR AVG | 19.86% | N/A |